Alzheimer's Disease and Medicinal Plants: An Overview
S Manoharan1, M Mohamed Essa2,3, A Vinoth4
1Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, Chidambaram, Tamil Nadu, India. sakshiman@rediffmail.com.
Advances in Neurobiology
|September 22, 2016
Summary
Alzheimer's disease (AD) poses a global health challenge. Research explores natural products as potential therapeutic targets for AD, offering cost-effective solutions.
Area of Science:
- Neuroscience
- Pharmacology
- Natural Products Chemistry
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder with significant global health and socioeconomic impact.
- AD affects individuals, caregivers, and society on personal, emotional, financial, and social levels.
- There is a critical need for cost-effective, long-term therapeutic targets for AD management.
Purpose of the Study:
- To review the potential benefits of natural products and their active components in managing Alzheimer's disease.
- To explore novel therapeutic avenues for neurodegenerative diseases.
Main Methods:
- Literature review of recent research on natural products and neurodegenerative diseases.
- Analysis of studies investigating the efficacy of natural compounds against AD pathology.
Main Results:
- Numerous studies indicate promising neuroprotective effects of various natural products.
- Specific active components from plants show potential in mitigating AD-related mechanisms.
- Natural products offer a promising area for developing AD therapeutics.
Conclusions:
- Natural products represent a viable and cost-effective strategy for Alzheimer's disease intervention.
- Further research into natural product-derived therapies is warranted for AD and other neurodegenerative conditions.
More Related Videos
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.7K
05:54Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
2.2K
Related Concept Videos
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:30Dementia
656
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
656
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
793
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:15Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339